Basic Information
HAEMODIALYSIS CONCENTRATE NKFS-03 (ACID) FOR BICARBONATE DIALYSIS
SOLUTION
Regulatory Information
SIN11033P
July 19, 1999
General Sale List
Therapeutic
HEMODIALYSIS
August 10, 2023
June 4, 2025
XB05ZA
Company Information
Active Ingredients
Strength: 3.58 g/l
Strength: 5.25 g/l
Strength: 216.19 g/l
Strength: 77.50 g/l
Strength: 7.77 g/l
Strength: 8.46 g/l
Detailed Information
Contraindications
**Contraindications** - Hyperkalaemia with the use of a potassium-containing acidic bicarbonate haemodialysis concentrate - Hypokalaemia with the use of a potassium-free acidic bicarbonate haemodialysis concentrate - Intractable coagulopathy In patients with unstable circulation and/or unstable blood pressure, a different extracorporeal method of treatment may be indicated.
Indication Information
**Indications** The indications below apply exclusively to the ready-to-use bicarbonate haemodialysis solution prepared from acid concentrate and bicarbonate concentrate following the specified dilution procedure: - Acute renal failure - Chronic renal failure - Hyperhydration - Intoxications - Compensation of acid-base and electrolyte balances - Adjustment of the blood / plasma / body temperature